Last reviewed · How we verify

NCT05965895

Ultrasound-Guided Continuous Serratus Anterior Plane Block vs Dexmedetomidine Infusion in Patients With Rib Fractures.

Status unknown Phase 4 Last updated 11 October 2023
What this trial tests

Phase 4 trial testing Ultrasound-guided continuous serratus anterior plane block in Pain in 150 participants. Status unknown.

Timeline
1 August 2023
Primary endpoint
1 August 2024
1 August 2024

Quick facts

Lead sponsorBeni-Suef University
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment150
Start date1 August 2023
Primary completion1 August 2024
Estimated completion1 August 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Beni-Suef University

Who can join

18 and older, any sex, with Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this work is to compare analgesic efficacy in patients with multiple rib fractures who will be managed with Ultrasound-guided continuous serratus anterior plane block versus patients who will be managed with dexmedetomidine infusion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ultrasound-guided continuous serratus anterior plane block

Trials testing the same drug.

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Beni-Suef University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05965895.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing